1. Improving 30-Day HF Readmission Rates With Biomarker-Guided Therapy

3. Heart Failure Epidemiology (US Data)

4. CHF Hospitalizations by Age, 2000 and 2010

5. Consequences of Heart Failure

6. Impact of Affordable Care Act on HF Readmission

7. Impact of Affordable Care Act on HF Readmission (cont)

8. EVEREST Study

9. EVEREST: NPs and Congestion Scores

10. Relationships Between Discharge BNP and Outcomes

11. Therapies With Effects on BNP Levels

12. DOSE-AHF Study

13. Telemonitoring and Home-based Care

14. The Importance of Serial NP Measurements for Prognostication in Chronic HF

15. PROTECT Study Primary End Point: Total Cardiovascular Events

16. PROTECT Secondary End Points: HF Hospitalization and Rehospitalization

17. Guided Therapy Combined Analyses Suggest Benefit, All-Cause Mortality

18. The GUIDE-IT Trial

19. Home Testing

20. Abbreviations

21. Abbreviations (cont)

22. Abbreviations (cont)

23. References

24. References (cont)

25. References (cont)

26. References (cont)